The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of PIK3CA mutation with pathological complete response in primary HER2-positive breast cancer: Combined analysis of 967 patients from three prospective clinical trials.
 
Sibylle Loibl
Honoraria - Novartis; Roche Pharma AG
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst); PharmaSea (Inst); Roche Pharma AG (Inst)
 
Ian Majewski
No Relationships to Disclose
 
Valentina Guarneri
Honoraria - GlaxoSmithKline
 
Valentina Nekljudova
No Relationships to Disclose
 
Eileen McCormick Holmes
No Relationships to Disclose
 
Emilio Bria
No Relationships to Disclose
 
Carsten Denkert
Research Funding - PharmaSea (Inst)
 
Holger Eidtmann
Research Funding - Ethicon (Inst)
 
Christos Sotiriou
Research Funding - PharmaSea (Inst)
 
Sherene Loi
Research Funding - PharmaSea (Inst)
 
Fabrice Andre
Honoraria - AstraZeneca; Novartis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Novartis
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Roche
 
Michael Untch
No Relationships to Disclose
 
Pier Franco Conte
No Relationships to Disclose
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Invivis; Lilly; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi; Symphony Evolution; Synthon; Verastem
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Invivis (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Symphony Evolution (Inst); Synthon (Inst); Verastem (Inst)
 
Gunter Von Minckwitz
Employment - GBG Forschungs
Leadership - GBG Forschungs
Stock and Other Ownership Interests - GBG Forschungs
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Teva (Inst)
 
Jose Baselga
No Relationships to Disclose